Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CStone Pharmaceuticals' CS5001 Enters Phase Ib Trial for Diffuse Large B-Cell Lymphoma
CompanyDrug

CStone Pharmaceuticals’ CS5001 Enters Phase Ib Trial for Diffuse Large B-Cell Lymphoma

March 6, 2025
Roche's Gazyva Receives FDA Review Acceptance for Lupus Nephritis Treatment
CompanyDrug

Roche’s Gazyva Receives FDA Review Acceptance for Lupus Nephritis Treatment

March 6, 2025
Ascentage Pharma's Olverembatinib Receives Third BTD in China for Ph+ ALL Treatment
CompanyDrug

Ascentage Pharma’s Olverembatinib Receives Third BTD in China for Ph+ ALL Treatment

March 6, 2025
ImmuneOnco's Timdarpacept (IMM01) and IMM2510 Receive NMPA Approval for Clinical Study in Advanced Malignant Tumors
CompanyDrug

ImmuneOnco’s Timdarpacept (IMM01) and IMM2510 Receive NMPA Approval for Clinical Study in Advanced Malignant Tumors

March 6, 2025
CSPC Pharma's JMT108 Receives NMPA Clinical Approval for Advanced Malignant Tumors
CompanyDrug

CSPC Pharma’s JMT108 Receives NMPA Clinical Approval for Advanced Malignant Tumors

March 6, 2025
Sandoz's Q4 2024 Results Show Strong Biosimilar Growth
Company

Sandoz’s Q4 2024 Results Show Strong Biosimilar Growth

March 6, 2025
Peijia Medical Completes First Two Implants of Trilogy THV System in Taiwan
CompanyMedical Device

Peijia Medical Completes First Two Implants of Trilogy THV System in Taiwan

March 6, 2025
Huadong Medicine's V30 Optical Radiofrequency Device Receives NMPA Review Approval
CompanyMedical Device

Huadong Medicine’s V30 Optical Radiofrequency Device Receives NMPA Review Approval

March 6, 2025
Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies
CompanyDeals

Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies

March 6, 2025
Bayer Posts Steady Q4 Growth, Pharmaceutical Sales Lead the Way
Company

Bayer Posts Steady Q4 Growth, Pharmaceutical Sales Lead the Way

March 6, 2025
NovoCare Pharmacy Offers Reduced-Cost Wegovy for Cash-Paying Patients
Company

NovoCare Pharmacy Offers Reduced-Cost Wegovy for Cash-Paying Patients

March 6, 2025
Antengene's Xpovio Receives Marketing Approval in Indonesia
CompanyDrug

Antengene’s Xpovio Receives Marketing Approval in Indonesia

March 6, 2025
1 2 … 229 230 231 232 233 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up